Guidance, NICE advice and quality standards in development | Guidance

Showing 241 to 250 of 404

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Obeticholic acid for treating liver fibrosis in people with steatohepatitis [ID1645]	Technology appraisal guidance	TBC
Odevixibat for treating cholestasis and pruritus in Alagille Syndrome [ID6181]	Technology appraisal guidance	TBC
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (Review of TA762) [ID6336]	Technology appraisal guidance	TBC
Olaparib with cediranib for treating platinum-resistant recurrent ovarian cancer after 1 or 2 therapies [ID4065]	Technology appraisal guidance	TBC
Olipudase alfa for treating Niemann-Pick disease types A and B [ID3913 ]	Highly specialised technology	TBC
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over ID6423	Technology appraisal guidance	13 August 2025
Omburtamab for treating relapsed neuroblastoma [ID1664]	Technology appraisal guidance	TBC
One-piece closed bags for adults with a colostomy: Late Stage Assessment	Health technology evaluation	TBC
Optical Coherence Tomography to guide percutaneous coronary intervention	Interventional procedures guidance	TBC
Oral paclitaxel with encequidar for treating advanced breast cancer [ID5111]	Technology appraisal guidance	TBC